Literature DB >> 28496768

Mortality Risk Associated with AF in Myocardial Infarction Patients.

Rajiv Sankaranarayanan1.   

Abstract

Atrial fibrillation (AF) complicating myocardial infarction (MI) has been a controversial topic for the last few decades. It has generated a plethora of debates regarding whether it is a risk indicator of co-morbidities and poor haemodynamic status or independent causal mediator of poor outcomes. The management of this condition has also been idiosyncratic probably due to confusion regarding its prognostic significance. We shall review the literature and attempt to elucidate the prognostic significance as well as evidence available for defining management strategies.

Entities:  

Year:  2012        PMID： 28496768      PMCID： PMC5153208     

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  88 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Atrial fibrillation in inferior wall Q-wave acute myocardial infarction.

Authors:  T Sugiura; T Iwasaka; N Takahashi; S Nakamura; H Taniguchi; Y Nagahama; M Matsutani; M Inada
Journal:  Am J Cardiol       Date:  1991-05-15       Impact factor: 2.778

Review 3.  Tachyarrhythmias in myocardial infarction.

Authors:  R W DeSanctis; P Block; A M Hutter
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

4.  Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.

Authors:  Igor Mrdovic; Lidija Savic; Gordana Krljanac; Jovan Perunicic; Milika Asanin; Ratko Lasica; Nebojsa Antonijevic; Nikola Kocev; Jelena Marinkovic; Zorana Vasiljevic; Miodrag Ostojic
Journal:  Coron Artery Dis       Date:  2012-01       Impact factor: 1.439

5.  Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial.

Authors:  Jonas Oldgren; Andrzej Budaj; Christopher B Granger; Yasser Khder; Juliet Roberts; Agneta Siegbahn; Jan G P Tijssen; Frans Van de Werf; Lars Wallentin
Journal:  Eur Heart J       Date:  2011-05-07       Impact factor: 29.983

6.  Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.

Authors:  Kent R Nilsson; Sana M Al-Khatib; Yi Zhou; Karen Pieper; Harvey D White; Aldo P Maggioni; Lars Kober; Christopher B Granger; Eldrin F Lewis; John J V McMurray; Robert M Califf; Eric J Velazquez
Journal:  Heart       Date:  2010-04-20       Impact factor: 5.994

7.  Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.

Authors:  C-K Wong; H D White; R G Wilcox; D A Criger; R M Califf; E J Topol; E M Ohman
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

8.  The relation between supraventricular tachyarrhythmias and left ventricular dysfunction after acute myocardial infarction.

Authors:  M Zoni Berisso; L Carratino; A Ferroni; E De Caro; G S Mela; C Vecchio
Journal:  Acta Cardiol       Date:  1988       Impact factor: 1.718

9.  Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

Authors:  Juan M Ruiz-Nodar; Francisco Marín; José Antonio Hurtado; José Valencia; Eduardo Pinar; Javier Pineda; Juan Ramón Gimeno; Francisco Sogorb; Mariano Valdés; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

10.  Paroxysmal atrial fibrillation and flutter associated with acute myocardial infarction: hemodynamic evaluation in relation to the development of arrhythmias and prognosis.

Authors:  Y Kobayashi; T Katoh; T Takano; H Hayakawa
Journal:  Jpn Circ J       Date:  1992-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.